RHOT1 and rheumatoid arthritis: Another study has demonstrated that the mitochondrial trafficking facilitator Miro1 mediates the inflammation and invasiveness in RA-FLS by binding to the mitochondrial calcium uniporter (MCU), making it a promising therapeutic target for inhibiting RA progression (59).